Log In
Print
BCIQ
Print
Print this Print this
 

MK-6096

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionDual orexin receptor antagonist
Molecular Target Orexin 1 receptor (HCRTR1) (OX1R) ; Orexin 2 receptor (HCRTR2) (OX2R)
Mechanism of ActionOrexin receptor antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today